Cronos Group (CRON) Reports Q4 Loss, Misses Revenue Estimates

分组1 - Cronos Group reported a quarterly loss of $0.01 per share, consistent with the Zacks Consensus Estimate, compared to a loss of $0.05 per share a year ago [1] - The company posted revenues of $30.3 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 13.43%, but showing an increase from $23.92 million year-over-year [2] - Cronos shares have declined approximately 8.4% since the beginning of the year, while the S&P 500 has gained 1.3% [3] 分组2 - The earnings outlook for Cronos is mixed, with the current consensus EPS estimate for the coming quarter at breakeven on $35.6 million in revenues, and $0.03 on $151.5 million in revenues for the current fiscal year [7] - The Medical - Drugs industry, to which Cronos belongs, is currently in the top 50% of Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]